Literature DB >> 23582328

A Direct in vivo RNAi screen identifies MKK4 as a key regulator of liver regeneration.

Torsten Wuestefeld1, Marina Pesic, Ramona Rudalska, Daniel Dauch, Thomas Longerich, Tae-Won Kang, Tetyana Yevsa, Florian Heinzmann, Lisa Hoenicke, Anja Hohmeyer, Anna Potapova, Ina Rittelmeier, Michael Jarek, Robert Geffers, Maren Scharfe, Frank Klawonn, Peter Schirmacher, Nisar P Malek, Michael Ott, Alfred Nordheim, Arndt Vogel, Michael P Manns, Lars Zender.   

Abstract

The liver harbors a distinct capacity for endogenous regeneration; however, liver regeneration is often impaired in disease and therefore insufficient to compensate for the loss of hepatocytes and organ function. Here we describe a functional genetic approach for the identification of gene targets that can be exploited to increase the regenerative capacity of hepatocytes. Pools of small hairpin RNAs (shRNAs) were directly and stably delivered into mouse livers to screen for genes modulating liver regeneration. Our studies identify the dual-specific kinase MKK4 as a master regulator of liver regeneration. MKK4 silencing robustly increased the regenerative capacity of hepatocytes in mouse models of liver regeneration and acute and chronic liver failure. Mechanistically, induction of MKK7 and a JNK1-dependent activation of the AP1 transcription factor ATF2 and the Ets factor ELK1 are crucial for increased regeneration of hepatocytes with MKK4 silencing.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23582328     DOI: 10.1016/j.cell.2013.03.026

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  53 in total

Review 1.  In vivo RNAi screens: concepts and applications.

Authors:  Shane Crotty; Matthew E Pipkin
Journal:  Trends Immunol       Date:  2015-04-27       Impact factor: 16.687

Review 2.  ATF2, a paradigm of the multifaceted regulation of transcription factors in biology and disease.

Authors:  Gregory Watson; Ze'ev A Ronai; Eric Lau
Journal:  Pharmacol Res       Date:  2017-02-15       Impact factor: 7.658

3.  Scalloped and Yorkie are required for cell cycle re-entry of quiescent cells after tissue damage.

Authors:  Joy H Meserve; Robert J Duronio
Journal:  Development       Date:  2015-07-09       Impact factor: 6.868

4.  Cancer: interference identifies immune modulators.

Authors:  Lars Zender
Journal:  Nature       Date:  2014-01-29       Impact factor: 49.962

Review 5.  RNAi screening comes of age: improved techniques and complementary approaches.

Authors:  Stephanie E Mohr; Jennifer A Smith; Caroline E Shamu; Ralph A Neumüller; Norbert Perrimon
Journal:  Nat Rev Mol Cell Biol       Date:  2014-09       Impact factor: 94.444

Review 6.  JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships.

Authors:  András Zeke; Mariya Misheva; Attila Reményi; Marie A Bogoyevitch
Journal:  Microbiol Mol Biol Rev       Date:  2016-07-27       Impact factor: 11.056

Review 7.  JNK signaling as a target for anticancer therapy.

Authors:  Kamal S Abdelrahman; Heba A Hassan; Salah A Abdel-Aziz; Adel A Marzouk; Atsushi Narumi; Hiroyuki Konno; Mohamed Abdel-Aziz
Journal:  Pharmacol Rep       Date:  2021-03-12       Impact factor: 3.024

8.  Integrative framework for identification of key cell identity genes uncovers determinants of ES cell identity and homeostasis.

Authors:  Senthilkumar Cinghu; Sailu Yellaboina; Johannes M Freudenberg; Swati Ghosh; Xiaofeng Zheng; Andrew J Oldfield; Brad L Lackford; Dmitri V Zaykin; Guang Hu; Raja Jothi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-07       Impact factor: 11.205

Review 9.  Hydrodynamic transfection for generation of novel mouse models for liver cancer research.

Authors:  Xin Chen; Diego F Calvisi
Journal:  Am J Pathol       Date:  2014-01-28       Impact factor: 4.307

Review 10.  Stable RNA interference rules for silencing.

Authors:  Christof Fellmann; Scott W Lowe
Journal:  Nat Cell Biol       Date:  2014-01       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.